Novo Nordisk A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0062498333
DKK
309.60
246.82 (393.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Genmab A/S
H. Lundbeck A/S
Zealand Pharma A/S
Bavarian Nordic A/S
Orphazyme A/S
Novo Nordisk A/S
Why is Novo Nordisk A/S ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Novo Nordisk A/S for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Novo Nordisk A/S
-100.0%
8.23
54.39%
OMX Copenhagen 20
-36.46%
-0.98
38.27%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
19.93%
EBIT Growth (5y)
19.86%
EBIT to Interest (avg)
18.19
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
0.56
Sales to Capital Employed (avg)
1.66
Tax Ratio
20.93%
Dividend Payout Ratio
50.28%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
84.59%
ROE (avg)
69.89%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
7.38
EV to EBIT
9.13
EV to EBITDA
8.22
EV to Capital Employed
5.32
EV to Sales
4.24
PEG Ratio
0.47
Dividend Yield
3.18%
ROCE (Latest)
58.27%
ROE (Latest)
66.09%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Novo Nordisk A/S
Operating Cash Flow - Annually
Highest at DKK 108,908.00 MM and Grown
each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (DKK MM)

Net Sales - Quarterly
At DKK 65,349 MM has Grown at 22.45 %
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (DKK MM)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at DKK 30,340 MM. and Grown
in each of the last 5 periods
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (DKK MM)

Profit Before Tax less Other Income (PBT) - Quarterly
At DKK 30,340 MM has Grown at 27.20 %
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (DKK MM)

Operating Profit (PBDIT) - Quarterly
Highest at DKK 35,328 MM.
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (DKK MM)

Operating Profit Margin - Quarterly
Highest at 54.06%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales (DKK MM)

Profit After Tax (PAT) - Quarterly
Highest at DKK 25,407 MM.
in the last five periods
MOJO Watch
Near term PAT trend is positive

PAT (DKK MM)

Profit After Tax (PAT) - Quarterly
At DKK 25,407 MM has Grown at 28.2 %
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (DKK MM)

Earnings per Share (EPS) - Quarterly
Highest at DKK 5.68
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (DKK)

Debtors Turnover Ratio- Half Yearly
Highest at 4.29 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Novo Nordisk A/S
Interest - Quarterly
At DKK 2,074 MM has Grown at 20,739,999,900.00 %
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (DKK MM)

Cash and Cash Equivalents - Half Yearly
Lowest at DKK 6,324.00 MM
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents (DKK MM)

Debt-Equity Ratio - Half Yearly
Highest at 0.18 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio